Basic regulatory science behind drug substance and drug product specifications of monoclonal antibodies and other protein therapeutics
In this review, we focus on providing basics and examples for each component of the protein therapeutic specifications to interested pharmacists and biopharmaceutical scientists with a goal to strengthen understanding in regulatory science and compliance. Pharmaceutical specifications comprise a lis...
Saved in:
Main Authors: | Patanachai K. Limpikirati (Author), Sorrayut Mongkoltipparat (Author), Thinnaphat Denchaipradit (Author), Nathathai Siwasophonpong (Author), Wudthipong Pornnopparat (Author), Parawan Ramanandana (Author), Phumrapee Pianpaktr (Author), Songsak Tongchusak (Author), Maoxin Tim Tian (Author), Trairak Pisitkun (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advances and challenges in therapeutic monoclonal antibodies drug development
by: Mariana Lopes dos Santos, et al.
Published: (2018) -
Data Management 101 for drug developers: A peek behind the curtain
by: Bryan Oronsky, et al.
Published: (2023) -
Therapeutic Monoclonal Antibodies and Antibody Products, Their Optimization and Drug Design in Cancers
Published: (2022) -
Surface proteomics and label-free quantification of Leptospira interrogans serovar Pomona.
by: Teerasit Techawiwattanaboon, et al.
Published: (2021) -
The Use of Biotechnological Drugs in Pediatrics on the Example of Monoclonal Antibodies: Clinical Pharmacology View
by: Alexey S. Kolbin, et al.
Published: (2021)